Home
Faculty Directory
Priya Nori, M.D.

Priya Nori, M.D.

Associate Professor, Department of Medicine (Infectious Diseases)

Associate Professor, Department of Orthopaedic Surgery

Medical Director, Department of Medicine Antibiotic Stewardship Program

Area of Research: 1. Effect of clinical decision support tools on physician antibiotic prescribing 2. Medical education in ID, stewardship, and infection prevention 3. Integration of rapid diagnostic technology into antimicrobial stewardship 4. Pandemic response, COVID

Contact Information

718.920.4622718.653.5294

Montefiore Medical Center
3411 Wayne Avenue, Room 4H
Bronx, NY 10467

Research Profiles PubMed Portal

Is this your profile? Edit profile

Professional Interests

Dr. Priya Nori is an Associate Professor of Medicine and Orthopedic Surgery at the Albert Einstein College of Medicine. She serves as Medical Director of the Antimicrobial Stewardship Program (ASP) and outpatient parenteral antibiotic therapy program (OPAT) at Montefiore Health System and is Program Director of the Infectious Diseases (ID) fellowship program. She is an alumna of the Johns Hopkins University and Albert Einstein College of Medicine, where she received the American Medical Women’s Association’s Glasgow-Rubin Achievement Award and was inducted into the Alpha Omega Alpha honor society. She completed her internship at Baylor College of Medicine, residency at the New York Presbyterian Hospital, Weill Cornell. She returned to Einstein/Montefiore for fellowship in infectious diseases then stayed on as faculty, 2013 onwards. She oversees stewardship operations at the Bronx campuses and ambulatory sites. She also serves as Medical Director of the Montefiore OPAT program, an innovative ID care management program lead by the Montefiore CMO.

Her primary academic focus is medical education and mentorship in ASP, Infection Prevention, and Emerging Infections. She leads ASP and ID educational initiatives throughout the medical center and has pioneered programs to improve antibiotic prescribing at all levels. She is widely published in the area of educational curricula and decision-support tools for stewardship and infection prevention, orthopedic infections, and novel diagnostic technology for rapid microbe identification. She also serves on the Infectious Diseases Society of America’s (IDSA) Subcommittee for Antimicrobial Stewardship Curricula, the Centers for Disease Control and Prevention/Society for Healthcare Epidemiology of America’s (CDC/SHEA) Outbreak Response Training Program Education Committee, the SHEA Antimicrobial Stewardship Committee, and is co-chair of the SHEA stewardship certificate track, 2019-2021. Under her leadership, Montefiore’s ASP was awarded the IDSA’s Stewardship Center of Excellence distinction in 2018. She is also course director of IDSNY’s fellows' course on stewardship, infection prevention, and hospital epidemiology. She was awarded ID fellowship “teacher of the year” in 2015, the Department of Medicine “rising star” award in 2017, and the "Sharon Silbiger Subspecialist Teacher of the Year" award in 2020

Selected Publications

COVID-19 Publications:

Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs. Mazdeyasna H, Nori P, Patel P, Doll M, Godbout E, Lee K, Noda AJ, Bearman G, Stevens MP.Curr Infect Dis Rep. 2020;22(9):23. doi: 10.1007/s11908-020-00734-x. Epub 2020 Jul 3.PMID: 32834785

Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck.Stevens MP, Patel PK, Nori P.Infect Control Hosp Epidemiol. 2020 Jun;41(6):744-745. doi: 10.1017/ice.2020.69.

Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge.

Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, Punjabi Katiyar C, Jain R, Aldrich M, Weston G, Gialanella P, Corpuz M, Gendlina I, Guo Y.Infect Control Hosp Epidemiol. 2020 Jul 24:1-5. doi: 10.1017/ice.2020.368. Online ahead of print.PMID: 32703320

Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.

Bushman D, Alroy KA, Greene SK, Keating P, Wahnich A, Weiss D, Pathela P, Harrison C, Rakeman J, Langley G, Tong S, Tao Y, Uehara A, Queen K, Paden CR, Szymczak W, Orner EP, Nori P, Lai PA, Jacobson JL, Singh HK, Calfee DP, Westblade LF, Vasovic LV, Rand JH, Liu D, Singh V, Burns J, Prasad N; CDC COVID-19 Surge Laboratory Group;, Sell J.MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):918-922. doi: 10.15585/mmwr.mm6928a5.PMID: 32678072

Prevalence of MRSA in Respiratory cultures and Diagnostic Performance of the MRSA Nasal PCR In Patients hospitalized with COVID-19 Pneumonia.

Punjabi C, Madaline T, Gendlina I, Chen V, Nori P, Pirofski LA.Infect Control Hosp Epidemiol. 2020 Aug 26:1-8. doi: 10.1017/ice.2020.440. Online ahead of print.PMID: 32843125

Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients. Nori P, Szymczak W, Puius Y, Sharma A, Cowman K, Gialanella P, Fleischner Z, Corpuz M, Torres-Isasiga J, Bartash R, Felsen U, Chen V, Guo Y.Int J Antimicrob Agents. 2020 Sep 25:106179. doi: 10.1016/j.ijantimicag.2020.106179. Online ahead of print.PMID: 32987104

Antimicrobial Stewardship Programs and Convalescent Plasma for COVID-19: A New Paradigm for Pre-Authorization? Stevens MP, Patel PK, Nori P.Infect Control Hosp Epidemiol. 2020 Sep 9:1-4. doi: 10.1017/ice.2020.459. Online ahead of print.PMID: 32900407 No abstract available.

Antimicrobial Stewardship and Bamlanivimab: Opportunities for Outpatient Preauthorization? Patel, P., Nori, P., & Stevens, M. (2020). Infection Control & Hospital Epidemiology, 1-5. doi:10.1017/ice.2020.1343

Nori, P., Patel, P., & Stevens, M. (2020). Rational allocation of COVID-19 vaccines to healthcare personnel and patients: A role for antimicrobial stewardship programs? Infection Control & Hospital Epidemiology, 1-6. doi:10.1017/ice.2020.1393

In the News

More Media Coverage

The FDA Revokes its Emergency Use Authorization for Hydroxychloroquine

Wired - June 17, 2020

Priya Nori, M.D., explains that the FDA's decision to revoke its Emergency Use Authorization for hydroxychloroquine to treat COVID-19 will have little impact on clinicians, many of whom had already shied away from using the antimalarial drug. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.
Antibiotic Treatment for COVID-19 Complications Could Fuel Resistant Bacteria

Science - April 16, 2020

Priya Nori, M.D. comments on the use of antibiotics in patients with COVID-19, which could help stem secondary bacterial infections. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.

Quick Links

Faculty Profile

Priya Nori, M.D.

Contact Information

Professional Interests

Selected Publications

In the News